219832-76-5 Usage
Uses
Used in Pharmaceutical Industry:
4-Piperidineacetic acid, .alpha.-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester is used as a chemical intermediate for the synthesis of various drugs, including antipsychotic and anticonvulsant medications. Its unique structure and properties make it a valuable building block in the development of these medications, contributing to their therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical industry, 4-Piperidineacetic acid, .alpha.-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester is utilized in the development of insecticides and herbicides. Its chemical properties allow it to be incorporated into formulations that effectively control pests and weeds, thereby enhancing crop protection and yield.
Overall, 4-Piperidineacetic acid, .alpha.-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester plays a significant role in both the pharmaceutical and agrochemical industries, serving as a key intermediate in the synthesis of various compounds with therapeutic and protective applications.
Check Digit Verification of cas no
The CAS Registry Mumber 219832-76-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,9,8,3 and 2 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 219832-76:
(8*2)+(7*1)+(6*9)+(5*8)+(4*3)+(3*2)+(2*7)+(1*6)=155
155 % 10 = 5
So 219832-76-5 is a valid CAS Registry Number.
219832-76-5Relevant academic research and scientific papers
Potent and selective bicyclic lactam inhibitors of thrombin: Part 2:P1 modifications
Plummer, Janet S.,Berryman, Kent A.,Cai, Cuiman,Cody, Wayne L.,Dimaio, John,Doherty, Annette M.,Edmunds, Jeremy J.,He, John X.,Holland, Debra R.,Levesque, Sophie,Kent, Darin R.,Narasimhan, Lakshmi S.,Rubin, J. Ronald,Rapundalo, Stephen T.,Siddiqui, M. Arshad,Susser, Alan J.,St-Denis, Yves,Winocour, Peter D.
, p. 3409 - 3414 (2007/10/03)
The synthesis and antithrombotic activity of a series of nonpeptide bicyclic thrombin inhibitors is described. We have explored the SAR with modifications to the P1 site. The introduction of arginine mimetics at the P1 site led to potent and selective thrombin inhibitors.
